Step Count Prescription Strategy Can Up Steps/Day

Share this content:
Step Count Prescription Strategy Can Up Steps/Day
Step Count Prescription Strategy Can Up Steps/Day

TUESDAY, Jan. 24, 2017 (HealthDay News) -- A physician-delivered step count prescription strategy with an individualized rate of increase can result in an increase in step count/day, according to a study published online Jan. 11 in Diabetes, Obesity and Metabolism.

Kaberi Dasgupta, M.D., from the McGill University Health Centre in Montreal, and colleagues examined the effects of physician-delivered step count prescriptions and monitoring. Participants were randomized to a control arm or an active arm, in which they were provided with pedometers and recorded step counts. Physicians reviewed their records over a one-year period and provided a written step count prescription with a goal of a 3,000-step/day increase (individualized rate of increase). Participants in the control arm were advised to engage in 30 to 60 minutes of physical activity per day. Seventy-nine percent of the 347 participants completed the final evaluation.

The researchers found that there was a net increase of 20 percent in steps/day for active versus control participants (1,190 steps). Inconclusive changes were seen in carotid femoral pulse wave velocity. Among participants with type 2 diabetes, active versus control participants experienced a lowering of hemoglobin A1c (−0.38 percent). The active versus control arm also showed a decrease in homeostasis model assessment-insulin resistance (−0.96 in all participants not treated with insulin).

"A simple physician-delivered step count prescription strategy incorporated into routine clinical practice led to a net 20 percent increase in step counts, though below the 3,000 steps/day targeted increment," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »